Skip to content
Screener

LeMaitre Vascular LMAT Total Liabilities & Equity

Total Liabilities & Equity at other companies

ITG
Integer HoldingsITGR
$3.41B+3.5%
Abbott logo
AbbottABT
$109.22B+30.0%
Baxter International logo
Baxter InternationalBAX
$19.85B-6.8%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$50.73B-7.6%
Artivion logo
ArtivionAORT
$1.07B+27.9%
Edwards Lifesciences logo
Edwards LifesciencesEW
$13.32B+2.3%

Other financials

Income statement

See full
Revenue$70.4M+9.6%
Gross profit$50.8M+12.9%
Operating income$20.4M+26.4%
Net income$17.1M+23.7%
EPS (diluted)$0.74+23.3%

Balance sheet

See full
Cash & equivalents$26.6M-2.0%
Total debt$21.2M+19.7%
Total equity$420.3M+15.9%
Total assets$640.5M+10.9%

Cash flow

See full
Operating cash flow$16.0M-21.3%
CapEx$2.3M+72.4%
Free cash flow$13.7M-28.0%

Valuation

See full
Market cap$1.86B-11.2%
Enterprise value$1.86B-11.0%
P/E28.4×-16.1×
P/S7.1×-1.8×

Profitability

See full
Gross margin72.9%+3.8pp
Operating margin29.5%+6.1pp
Net margin25%+4.9pp
FCF margin28.1%+5.8pp

Returns & leverage

See full
Return on equity16.8%+3.0pp
Debt / equity0.1×0.0×
Current ratio16.3×+2.4×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 6:30 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333762
Line item(unaudited) / June 30, 2026December 31, 2025
Preferred stock, $0.01 par value; 3,000,000 shares authorized; none issued and outstanding
Common stock, $0.01 par value; 37,000,000 shares authorized, 24,494,202 and 24,396,904 shares issued, 22,864,935 and 22,772,607 shares outstanding, respectively245244
Additional paid-in capital236,161228,407
Retained earnings206,017184,715
Accumulated other comprehensive loss(4,165)(2,411)
Treasury stock, at cost; 1,629,267 and 1,624,297 shares, respectively(17,916)(17,439)
Total stockholders’ equity420,342393,516
Total liabilities and stockholders’ equity$640,549$615,690

Item 1. Financial Statements

FAQ

What is LeMaitre Vascular's total liabilities & equity?
LeMaitre Vascular (LMAT) reported total liabilities & equity of $640.55M in Q2 2026.
How has LeMaitre Vascular's total liabilities & equity changed year-over-year?
LeMaitre Vascular's total liabilities & equity increased by 10.9% year-over-year, from $577.59M to $640.55M.
What is the long-term trend for LeMaitre Vascular's total liabilities & equity?
Over 5 years (2020 to 2025), LeMaitre Vascular's total liabilities & equity has grown at a 19.5% compound annual growth rate (CAGR), from $252.81M to $615.69M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about LeMaitre Vascular's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude